We have selected case studies focused on innovations already deployed in London – illustrating how the six programmes of the London Life Sciences Strategy could help them generate even greater positive impact:

• Type 1 Diabetes – Hybrid Closed Loop (HCL) Adoption
• Cardiovascular disease – AI tool for proactive prevention
• Cardiovascular disease – detection solution

Additionally, we have developed a case study outlining the “art of the possible”; deploying a new pharmaceutical product London-wide while generating real-world evidence and pharmacogenomic insight.